Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
...ral gelcap) PHASE 3 and PHASE 4 CLINICAL
is in a pivotal Phase 3 and Phase 4 clinical progr... The clinical plan to support an NDA approval for sulodexide
Subpart H (accelerated approval), as agreed ...FDA, as a condition to the accelerated
approval of sulodexide
based on the Phase 3 clinical trial, that the Phas...
Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
... No Safety Concerns Raised sulodexide
Phase 3 study to continue without modification
NEW YORK, Dec. 5 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals
(Nasdaq: KERX ) today announced ...
Keryx Biopharmaceuticals, Inc. Announces Poster Presentations
Highlighting Mechanism of Action and Clinical Activity of
Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American
Diabetes Association 67th Scientific Sessions in Chicago, Illinois
...ditional abstracts of interest include:
2220 - Oral Administration of sulodexide
for the Treatment of Diabetic
Nephropathy in a Phase II Study has Mini... AZ, Washington,
DC, Baltimore, MD
2376 - Efficacy and Safety of sulodexide
in the Treatment of Diabetic
Nephropathy RAM WEISS, ROBERT M. NIECEST...